Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:25:42.777Z.
Calculation as of: 2026-10-06T15:25:42.777Z.
Quote observation: 2026-10-06T15:24:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1aa4897ea94b4447735fa2b7e4a8bb5a18d1bcefabda34b81af7232f4abbcb6a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$6.62M
Free Cash Flow Yield
N/A
TTM Avg
0.05%
3Y Avg
0.04%
5Y Avg
0.03%
Market Cap
$6.49M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.39M
Free Cash Flow Yield
N/A
TTM Avg
1.12%
3Y Avg
0.90%
5Y Avg
0.90%
Market Cap
$7.02M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.13M
Free Cash Flow Yield
N/A
TTM Avg
17.66%
3Y Avg
16.46%
5Y Avg
16.46%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.66M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.62M | N/A | 0.05% | 0.04% | 0.03% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.49M | N/A | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.39M | N/A | 1.12% | 0.90% | 0.90% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.19M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | N/A | 17.66% | 16.46% | 16.46% |
| Biomerica, Inc. (BMRA)vs › | $6.21M | N/A | 0.78% | 0.78% | 0.78% |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | N/A | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.05M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
